1 year return (CAGR)
-28.56%
Intellia Therapeutics Inc Exchange (NASDAQ, USD)
NTLA
12.33
-0.36 (-2.84%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-29.39%
5 year return (CAGR)
-39.37%
10 year return (CAGR)
-4.63%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.73B
Price/Sales
29.04
Ent value
1.75B
Price/Book
2.37
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
9.70%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.74 |
| Daily high | 12.85 |
| Daily low | 11.96 |
| Daily Volume | 5.03M |
| All-time high | 176.78 |
| 1y analyst estimate | 23.94 |
| Beta | 1.82 |
| EPS (TTM) | -3.00 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| NTLA | S&P500 | |
| Current price drop from All-time high | -93.03% | -1.29% |
| Highest price drop | -96.45% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -58.06% | -10.68% |
| Avg time to new high | 62 days | 12 days |
| Max time to new high | 1268 days | 1805 days |
News
